ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,341, issued on Sept. 30, was assigned to The United States of America, as represented by the Secretary of the Navy (Washington).
"Luminescence-based method for planning precisely delivered ion beam therapy" was invented by Ross S. Fontenot (Montgomery Village, Md.), William A. Hollerman (Lafayette, La.) and Noel A. Guardala (Columbia, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Exemplary practice of the present invention implements Europium Tetrakis Dibenzoylmethide Triethylammonium (EuD4TEA) so as to administer ion beam therapy with extreme precision. An EUD4TEA-inclusive marker (e.g., a solid or gel) is exactingly placed on the skin of a p...